The DOI matches its Crossref record; 76 of the 79 references it cites were found in a registry or an index.
Pharmacist interventions in the management of type 2 diabetes mellitus: a systematic review of randomized controlled trials.
Open accessAbstract
BACKGROUND: Diabetes mellitus is a major health problem that is growing rapidly worldwide. A collaborative and integrated team approach in which pharmacists can play a pivotal role should be sought when managing patients with diabetes. OBJECTIVE: To identify and summarize the main outcomes of pharmacist interventions in the management of type 2 diabetes. METHODS: PubMed, Cochrane Central Register of Controlled Trials, and Web of Science were searched for randomized controlled trials evaluating the effectiveness of any pharmacist intervention directed at patients with type 2 diabetes in comparison with usual care. Outcome measures of interest included glycosylated hemoglobin (Alc), blood glucose, blood pressure, lipid profile, body mass index (BMI), 10-year coronary heart disease (CHD) risk, medication adherence, health-related quality of life (HRQoL), and economic outcomes. The risk of bias in included studies was assessed using the Cochrane risk of bias tool. RESULTS: Thirty-six studies were included in this systematic review, involving 5,761 participants. The studies evaluated the effects of several pharmacist interventions carried out in various countries and in different health care facilities, such as community pharmacies, primary care clinics, and hospitals. The number of studies reporting each outcome of interest varied. Alc was evaluated in 26 studies, of which 24 reported a greater reduction in this outcome in the intervention group compared with the control group, with the difference in change between groups ranging from -0.18% to -2.1%. Eighteen studies assessed change in systolic blood pressure, of which 17 studies reported a greater improvement in this outcome in the intervention group, with the difference in change between groups varying between -3.3 mmHg and -23.05 mmHg. For diastolic blood pressure, a greater effect was also observed in the intervention group in 14 out of 15 studies, with the difference in change between groups varying between -0.21 mmHg and -9.1 mmHg. Thirteen studies described total cholesterol as an outcome measure, of which 10 reported a greater improvement in this outcome in the intervention group, with the difference in change between groups ranging from +18.95 mg dL(-1) to -32.48 mg dL(-1). With regard to low-density lipoprotein cholesterol, a greater reduction in this parameter in the intervention group was documented in 12 out of 15 studies, with the difference in change between groups varying between +7.35 mg dL(-1) and -30 mg dL(-1). Similarly, favorable data were reported on high-density lipoprotein cholesterol in the intervention group in 9 out of 12 studies that assessed this outcome, with the difference in change between groups ranging from -5.8 mg dL(-1) to +11 mg dL(-1). Data on triglycerides were also reported in 12 studies, of which 9 reported a greater reduction in triglycerides levels in the intervention group, with the difference in change between groups varying between +12 mg dL(-1) and -62 mg dL(-1). Overall, a beneficial effect on BMI was also described in the intervention group in 12 out of 14 studies. Of note, in all 6 studies that estimated the 10-year CHD risk among study patients, a greater improvement in the intervention group versus the control group was found. In addition, pharmacist interventions also had a positive impact on medication adherence and HRQoL in most studies that ascertained these outcomes. Finally, although only 3 studies conducted a cost-effectiveness analysis, pharmacist interventions proved to be cost-effective. CONCLUSIONS: The findings from this review clearly support the involvement of pharmacists as members of health care teams in the management of patients with type 2 diabetes. DISCLOSURES: This systematic review was not funded. The authors declare that they have no conflicts of interest. Concept and study design were created by Pousinho, Morgado, and Alves. Pousinho took the lead in data collection, along with Alves, and data interpretation was performed by Pousinho, Falcão, and Alves. The manuscript was primarily written by Pousinho, along with Alves, and revised by Alves, Morgado, and Falcão.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“our study findings on real practice settings follow similar trends to those reported in randomized controlled trials.”
From Using Dispensing Data to Evaluate Adherence Implementation Rates in Community Pharmacy (2019) · cites this paper as Pousinho et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,586
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
the CONSORT Group, Schulz, K. F., Altman, D. G., & Moher, D. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-18 · Cited by 13,371
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials
Schulz, K. F., Altman, D. G., Moher, D., & for the CONSORT Group (2010) · BMJ · doi:10.1136/bmj.c332 · Cited by 9,329
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Research works printed but not linked: 14
- International Diabetes Federation, 2015, IDF Diabetes Atlas
- Hepler CD, 1990, Am J Hosp Pharm, 47, 533
- Choe HM, 2005, Am J Manag Care, 11, 253
- Adepu R, 2010, Asian J Pharm Clin Res, 3, 174
- Chung WW, 2014, Patient Prefer Adherence, 8, 1185
- Farsaei S, 2011, J Res Med Sci, 16, 43
- Ghosh S, 2010, Int J Pharma Bio Sci, 1, 1
- Mahwi TO, 2013, Int J Pharm Sci Res, 4, 1363
- Ramanath KV, 2011, Asian J Pharm Clin Res, 4, 15
- Sriram S, 2011, J Res Med Sci, 16, S412
- Suppapitiporn S, 2005, J Med Assoc Thai, 88, S134
- 10.1042/cs1010671 · DOI · Paper page
- Rodríguez NFA, 2007, Pharm Care Esp, 9, 2
- Kozma CM, 1993, Clin Ther, 15, 1121
Cited by
Sorted by citations
Cardiovascular disease as a leading cause of death: how are pharmacists getting involved?
Namara, K. M., Alzubaidi, H., & Jackson, J. K. (2019) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s133088 · Cited by 414
Presley, B., Groot, W. N. J., & Pavlova, M. (2018) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2018.09.021 · Cited by 178
OECD (2021) · OECD Reviews of Health Systems · doi:10.1787/120e170e-en · Cited by 171
Newman, T. V., San-Juan-Rodriguez, A., Parekh, N., Swart, E. C. S., Klein‐Fedyshin, M., Shrank, W. H., & Hernandez, I. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2019.12.016 · Cited by 158
van Eikenhorst, L., Taxis, K., van Dijk, L., & de Gier, H. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00891 · Cited by 121
Hughes, J., Wibowo, Y. I., Sunderland, B., & Hoti, K. (2017) · Integrated Pharmacy Research and Practice · doi:10.2147/iprp.s103783 · Cited by 108
Fazel, M. T., Bagalagel, A., Lee, J. K., Martin, J. R., & Slack, M. K. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028017711454 · Cited by 99
Alshehri, A. A., Jalal, Z., Cheema, E., Haque, M. S., Jenkins, D., & Yahyouche, A. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14164 · Cited by 88
Korcegez, E. I., Sancar, M., & Demirkan, K. (2017) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2017.23.5.573 · Cited by 82
Abdulrhim, S. H., Sankaralingam, S., Ibrahim, M. I. M., & Awaisu, A. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2019.12.007 · Cited by 83
Bukhsh, A., Khan, T. M., Lee, S. W. H., Lee, L., Chan, K., & Goh, B. H. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00339 · Cited by 69
Benedict, A. W., Spence, M. M., Sie, J. L., Chin, H. A., Ngo, C. D., Salmingo, J. F., Vidaurreta, A. T., & Rashid, N. (2018) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2018.24.2.114 · Cited by 66
Dolovich, L. R., Austin, Z., Waite, N. M., Chang, F., Farrell, B. J., Grindrod, K., Houle, S. K. D., McCarthy, L. M., MacCallum, L., & Sproule, B. A. (2018) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163518815717 · Cited by 66
Blood Sugar Regulation for Cardiovascular Health Promotion and Disease Prevention
Schwarz, P. E. H., Timpel, P., Harst, L., Greaves, C. J., Ali, M. K., Lambert, J. D., Weber, M. B., Almedawar, M. M., & Morawietz, H. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.081 · Cited by 66
OECD Reviews of Health Systems
OECD (2009) · OECD Reviews of Health Systems · doi:10.1787/19901410 · Cited by 52
Huang, Y., Pecanac, K. E., & Shiyanbola, O. O. (2020) · Qualitative Health Research · doi:10.1177/1049732320945296 · Cited by 59
Improving Medication Adherence in Coronary Heart Disease
Zullig, L. L., Ramos, K., & Bosworth, H. B. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0918-y · Cited by 48
Nogueira, M., Otuyama, L. J., Rocha, P. A., & Pinto, V. B. (2020) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2020rw4686 · Cited by 51
Brewster, S., Holt, R. I. G., Portlock, J. C., & Price, H. C. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-137511 · Cited by 47
Correr, C. J., Coura‐Vital, W., Frade, J. C. Q. P., do Nascimento, R. C. R. M., Nascimento, L. G., Pinheiro, E. B., Ferreira, W. M., Reis, J. S., Melo, K., Pontarolo, R., et al. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00593-5 · Cited by 46
Social Determinants of Poor Management of Type 2 Diabetes Among the Insured
Patel, M. R. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-01354-4 · Cited by 43
Bukhsh, A., Tan, X. W., Chan, K., Lee, L., Goh, B. H., & Khan, T. M. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s180256 · Cited by 40
Pharmacists' Attitudes and Role in Diabetes Management in Kuwait
Al‐Haqan, A., Al-Taweel, D. M., Awad, A. I., & Wake, D. J. (2017) · Medical Principles and Practice · doi:10.1159/000456088 · Cited by 40
Khan, Y. H., Alzarea, A. I., Alotaibi, N. H., Alatawi, A. D., Khokhar, A., Alanazi, A. S., Butt, M. H., Alshehri, A. A., Alshehri, S., Alatawi, Y. M., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191610060 · Cited by 37
Angibaud, M., Jourdain, M., Girard, S., Rouxel, L., Mouhib, A., Nogueira, A., Rat, C., & Huon, J. (2024) · BMC Family Practice · doi:10.1186/s12875-024-02326-3 · Cited by 36
Using Dispensing Data to Evaluate Adherence Implementation Rates in Community Pharmacy
Torres-Robles, A., Wiecek, E., Cutler, R., Drake, B., Benrimoj, S. I., Fernandez-Llimos, F., & Garcia-Cardenas, V. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00130 · Cited by 33
Primary Care Providers’ Use of Pharmacist Support for Delivery of Pharmacogenetic Testing
Haga, S. B., Mills, R. A., Moaddeb, J., LaPointe, N. M. A., Cho, A., & Ginsburg, G. S. (2017) · Pharmacogenomics · doi:10.2217/pgs-2016-0177 · Cited by 33
Diabetes care in Qatar: a survey of pharmacists’ activities, attitudes and knowledge
Hajj, M. S. E., Abuyousef, S., & Basri, M. A. (2017) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-017-0562-z · Cited by 33
Bukhsh, A., Nawaz, M. S., Ahmed, H. S., & Khan, T. M. (2018) · Medicine · doi:10.1097/md.0000000000009847 · Cited by 34
Michiels, Y., Bugnon, O., Chicoye, A., Dejager, S., Moisan, C., Allaert, F., Hunault, C., Romengas, L., Méchin, H., & Vergès, B. L. (2019) · Advances in Therapy · doi:10.1007/s12325-019-00957-y · Cited by 36
Huang, Y., Shiyanbola, O. O., Chan, H., & Smith, P. D. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1749499 · Cited by 39
Clinical Pharmacy Services in a Multidisciplinary Specialty Pain Clinic
Semerjian, M., Durham, M. J., Mirzaian, E., Lou, M., & Richeimer, S. H. (2018) · Pain Practice · doi:10.1111/papr.12745 · Cited by 32
Advanced pharmacist practice: where is the United Kingdom in pursuit of this ‘Brave New World’?
Forsyth, P., & Rushworth, G. F. (2021) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-021-01276-5 · Cited by 32
Yaghoubi, M., Mansell, K. D., Vatanparastc, H., Steeves, M., Zeng, W., & Farag, M. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.09.014 · Cited by 32
Desse, T. A., Vakil, K., Namara, K. M., & Manias, E. (2021) · Diabetic Medicine · doi:10.1111/dme.14526 · Cited by 30
The relationship between diabetes distress, medication taking, glycaemic control and self-management
Alzubaidi, H., Sulieman, H., Namara, K. M., Samorinha, C., & Browning, C. J. (2021) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-021-01322-2 · Cited by 34
Pousinho, S., Morgado, M., Plácido, A. I., Roque, F., Falcão, A. C., & Alves, G. (2020) · Pharmacy Practice · doi:10.18549/pharmpract.2020.3.2000 · Cited by 30
Barba, E. L., de Miguel, M. R., Hernández‐Mijares, A., Alonso-Moreno, F. J., Peña, M. L. O., Aceituno, S., & Dáder, M. J. F. (2017) · Patient Preference and Adherence · doi:10.2147/ppa.s122556 · Cited by 27
Effectiveness of Quality Improvement Strategies for the Management of CKD
Silver, S. A., Bell, C. M., Chertow, G. M., Shah, P. S., Shojania, K. G., Wald, R., & Harel, Z. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02490317 · Cited by 30
Gautier, J., Boîtard, C., Michiels, Y., Raymond, G., Vergez, G., & Guedon, G. (2021) · Patient Education and Counseling · doi:10.1016/j.pec.2021.02.022 · Cited by 27
Mohamed, H. F., Allam, M. M., Hamdy, N. A., Ghazy, R. M., & Emara, R. H. (2021) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514211056307 · Cited by 24
Effectiveness of telepharmacy diabetes services: A systematic review and meta-analysis
Cao, D. X., Tran, R. J. C., Yamzon, J., Stewart, T. L., & Hernandez, E. A. (2022) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxac070 · Cited by 27
Lum, Z. K., Chang, K. L., Tsou, K. Y. K., Tan, J. Y., Wong, C. S. M., Kok, Z. Y., Kwek, S. C., Gallagher, P., & Lee, J. V. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109238 · Cited by 22
Contreras‐Vergara, A. L., Sifuentes-Franco, S., Haack, S. L., Graciano‐Machuca, O., Rodríguez-Carrizález, A. D., López-Contreras, A. K., Reyes‐Pérez, I. V., & Huerta-Olvera, S. G. (2022) · Patient Preference and Adherence · doi:10.2147/ppa.s370323 · Cited by 21
Robinson, A., O’Brien, N., Sile, L., Guraya, H. K., Govind, T., Harris, V., Pilkington, G., Todd, A., & Husband, A. (2022) · Health Expectations · doi:10.1111/hex.13611 · Cited by 21
Diabetes outcomes before and during telehealth advancements surrounding COVID-19
Woodhouse, A., Orvin, C., Rich, C., Crosby, J. F., & Keedy, C. A. (2021) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2021.09.011 · Cited by 21
Presley, B., Groot, W. N. J., & Pavlova, M. (2021) · BMC Health Services Research · doi:10.1186/s12913-021-07242-1 · Cited by 19
Al‐Taie, A., & Sheta, N. (2023) · Clinical Therapeutics · doi:10.1016/j.clinthera.2023.10.016 · Cited by 19
Lake, J. D., Rosenberg-Yunger, Z. R. S., Dainty, K. N., von den Baumen, T. R., Everall, A. C., & Guilcher, S. J. T. (2020) · BMC Health Services Research · doi:10.1186/s12913-020-05237-y · Cited by 18
David, E. A., Soremekun, R. O., Abah, I. O., & Aderemi-Williams, R. I. (2021) · Pharmacy Practice · doi:10.18549/pharmpract.2021.3.2402 · Cited by 19
Tait, P., Chakraborty, A., & Tieman, J. (2020) · Pharmacy · doi:10.3390/pharmacy8030143 · Cited by 17
Sherrill, C. H., Lee, S., & Bradley, C. L. (2021) · Currents in Pharmacy Teaching and Learning · doi:10.1016/j.cptl.2021.11.021 · Cited by 20
Al-Arkee, S., & AlAni, O. A. (2023) · International Journal of Pharmacy Practice · doi:10.1093/ijpp/riad013 · Cited by 17
Morath, B., Mayer, T., Send, A. F. J., Hoppe‐Tichy, T., Haefeli, W. E., & Seidling, H. M. (2017) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13318 · Cited by 17
Júnior, G. A. D. S., Silva, R. D. O. S., Onozato, T., Silvestre, C. C., Rocha, K. S. S., Araújo, E. M., & de Lyra, D. P. (2020) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13448 · Cited by 20
Hassan, F., Hatah, E., Ali, A. M., & Wen, C. W. (2023) · BMC Health Services Research · doi:10.1186/s12913-022-08977-1 · Cited by 20
Cahyaningsih, I., Lambert, M., Ochi, T., Li, F., Li, X., Denig, P., & Taxis, K. (2023) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2023.04.124 · Cited by 18
Acceptance rate of clinical pharmacists’ recommendations—an ongoing journey for integration
Peled, O., Vitzrabin, Y., Ner, E. B., Lazaryan, M., Berlin, M., Barchel, D., Berkovitch, M., Beer, Y., & Tamir, E. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1253990 · Cited by 16
Abdulrhim, S. H., Saleh, R. A., Hussain, M. A. M., Raey, H. A., Babiker, A. H., Kheir, N. M., & Awaisu, A. (2019) · Value in Health Regional Issues · doi:10.1016/j.vhri.2018.12.002 · Cited by 16
Halalau, A., Ince, M. S., Uddin, A., Karabon, P., Scherzer, Z. A., & Keeney, S. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-00983-y · Cited by 16
MacCallum, L., Mathers, A., Kellar, J., Rousse-Grossman, J., Moore, J. E., Lewis, G. F., & Dolovich, L. R. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.04.004 · Cited by 16
Edupuganti, S., Bushman, J., Maditz, R., Kaminoulu, P., & Halalau, A. (2019) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-019-0084-9 · Cited by 16
Firkus, D. M., McCoy, R. G., Matulis, J. C., Kessler, M., Mara, K. C., & Herges, J. R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0280654 · Cited by 15
Implementation of a Pharmacist-Led Diabetes Management Protocol.
Al-Omar, L. T., Anderson, S. L., Cizmic, A. D., & Vlasimsky, T. B. (2019) · Europe PMC (PubMed Central) · Cited by 15
Follow-up in community pharmacy should be routine, not extraordinary
MacCallum, L., & Dolovich, L. R. (2018) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/1715163518756586 · Cited by 15
Shaw, C., & Couzos, S. (2021) · Australian Journal of General Practice · doi:10.31128/ajgp-08-20-5565 · Cited by 14
Development of a primary care pharmacy outcomes framework: An umbrella literature review
Weir, N., Preston, K., Newham, R., & Bennie, M. (2021) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2021.07.010 · Cited by 15
Nguyen, T. H. P., Tran, T. T. T., Nguyen, N. K., Diep, H. G., Vo, S., Taxis, K., Pham, S. T., & Nguyen, T. N. (2022) · International Journal of Pharmacy Practice · doi:10.1093/ijpp/riac030 · Cited by 16
Social media health interventions to improve diabetes mellitus patient outcome: a systematic review
Alfian, R., Athiyah, U., & Nita, Y. (2021) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2020-0501 · Cited by 17
Mikhael, E. M., Hassali, M. A., Hussain, S. A., Nouri, A. I., & Shawky, N. (2019) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-019-00720-7 · Cited by 13
Pharmacist interventions for persons with intellectual disabilities: A scoping review
Lee, C., Ivo, J., Carter, C., Faisal, S., Shao, Y. W., & Patel, T. (2020) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.03.009 · Cited by 13
Pharmacists' Scope of Practice: Supports for Canadians with Diabetes
Mansell, K. D., Edmunds, K., & Guirguis, L. M. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.08.243 · Cited by 12
Sauriasari, R., Hening, W., & Sartika, R. A. D. (2019) · Journal of Research in Pharmacy Practice · doi:10.4103/jrpp.jrpp_19_67 · Cited by 17
Joseph, T., Hale, G. M., Moreau, C. S., Rosario, E., Logan, N., & Pérez, A. (2020) · Journal of Pharmacy Practice · doi:10.1177/0897190020977740 · Cited by 12
Kleiner, M. M., & Koumenta, M. (2022) · doi:10.17848/9780880996877 · Cited by 12
Liang, Y., Wang, K.-H., Huang, H., Shia, B., Chan, S.-Y., Ho, C.-W., Liu, C., & Chen, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19074234 · Cited by 12
Diabetes and Frail Older Patients: Glycemic Control and Prescription Profile in Real Life
Mangé, A.-S., Pagès, A., Sourdet, S., Cestac, P., & McCambridge, C. (2021) · Pharmacy · doi:10.3390/pharmacy9030115 · Cited by 11
A qualitative assessment of West Virginia pharmacist activities and attitude in diabetes management
Shatnawi, A. A., & Latif, D. A. (2016) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12677 · Cited by 11
Nasution, A., Dalimunthe, A., & Khairunnisa, K. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.519 · Cited by 11
The Excellence of Pharmacy Service: Past, Present and Future
Mohiuddin, A. K. (2019) · International Journal of Clinical and Developmental Anatomy · doi:10.11648/j.ijcda.20190502.12 · Cited by 12
Moreau, C. S., Sando, K. R., & Zambrano, D. H. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028016685731 · Cited by 10
Donihi, A. C., Moorman, J. M., Abla, A., Hanania, R., Carneal, D., & MacMaster, H. W. (2018) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1041 · Cited by 11
Glycemic Control and Management in Pharmacist-Led Diabetic Clinic vs. Physician-Led Diabetic Clinic
Alghadeer, S. M., Alsuwayni, B. M., Almuwayjid, A. K., Almadi, M. S., Mubarak, A. M., bin Khunayn, R. M., & Al-Arifi, M. N. (2021) · Medicina · doi:10.3390/medicina58010014 · Cited by 9
Miller, D. R., Reisman, J. I., McDannold, S. E., Kleinberg, F., Gillespie, C., Zogas, A., Ndiwane, N., Ourth, H. L., Morreale, A. P., Tran, M. H., et al. (2023) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxad176 · Cited by 9
Witry, M. J., Ernzen, M., Pape, A., & Viyyuri, B. R. (2019) · Pharmacy · doi:10.3390/pharmacy7030076 · Cited by 9
Impact of a Clinical Pharmacist Intervention Program on the Follow-up of Type-2 Diabetic Patients
Ebid, A.-H. I. M., Mobarez, M. A., Ramadan, R., & Mahmoud, M. (2020) · Hospital Pharmacy · doi:10.1177/0018578720973881 · Cited by 11
Paiva, A. R., Plácido, A. I., Curto, I., Morgado, M., Herdeiro, M. T., & Roque, F. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18147401 · Cited by 9
Couzos, S., Smith, D., Stephens, M., Preston, R., Hendrie, D. V., Loller, H., Tremlett, M., Nugent, A., Vaughan, F., Crowther, S. P., et al. (2019) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2019.12.022 · Cited by 9
Salem, H. H., Bazan, N. S., Addal, W. A., Alkhmash, M., Bana, M. A., Awad, S. M. A., Asiri, H. S., Alwadei, S. D., & Khaled, A. (2024) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.14121 · Cited by 8
Gagnon, A., Jin, M., Malak, M., Bednarowski, K., Feng, L., Francis-Pringle, S., Lu, S., Mallin, A., Skokovic-Sunjic, D., & Vedelago, A. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.08.240 · Cited by 7
Ramzan, B., Harun, S. N., Butt, F. Z., Butt, R. Z., Hashmi, F., Gardezi, S. H., Hussain, I., & Rasool, M. F. (2022) · Archives of Pharmacy Practice · doi:10.51847/2njmwzsnld · Cited by 7
Implementation of a pharmacist-led diabetes management service in an endocrinology clinic
Parsiani, R., Lundy, R., Ahmann, A., Joarder, F., & Castle, J. R. (2022) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2022.08.012 · Cited by 8
Medication economic burden of antidepressant non-adherence in Spain
Gutiérrez‐Abejón, E., Pedrosa-Naudín, M. A., Fernández‐Lázaro, D., & Alvarez, E. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1266034 · Cited by 6
Disadvantaged groups have greater spatial access to pharmacies in New York state
Suri, A., Quinn, J. W., Balise, R. R., Feaster, D. J., El‐Bassel, N., & Rundle, A. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-10901-8 · Cited by 6
Berard, L., Pockett, S. A., Roscoe, R. S., & Siemens, R. L. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00939-2 · Cited by 6
Fukunaga, K., & Tan, C. (2020) · Journal of Contemporary Pharmacy Practice · doi:10.37901/jcphp19-00015 · Cited by 6
Ramzan, B., Harun, S. N., Butt, F. Z., Butt, R. Z., Hashmi, F., Gardezi, S. H., Hussain, I., & Rasool, M. F. (2022) · Annals of Pharmacy Education Safety and Public Health Advocacy · doi:10.51847/hm2eyhinlp · Cited by 6
Suprapti, B., Izzah, Z., Yoshida, M. A., Puspitasari, A. D., & Nugroho, C. W. (2022) · Pharmacy Education · doi:10.46542/pe.2022.221.795804 · Cited by 6
Identifying pharmacy gaps: a spatiotemporal study of multimodal accessibility throughout the day
Viana, C. M., Encalada-Abarca, L., Rocha, J., & Vale, D. (2025) · International Journal of Health Geographics · doi:10.1186/s12942-025-00396-9 · Cited by 5
Impacto da consulta farmacêutica em pacientes polimedicados com alto risco cardiovascular
Reis, W. C. T., Bernardo, C. D. S., de Souza, T. T., Bonetti, A. D. F., & Fávero, M. L. D. (2019) · Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde · doi:10.30968/rbfhss.2018.092.003 · Cited by 5
Metadata
- Authors
- Pousinho, S., Morgado, M., Falcão, A., & Alves, G.
- Affiliations
- University of Beira Interior (PT)
- Centro de Neurociências e Biologia Celular (PT)
- Venue
- Journal of Managed Care & Specialty Pharmacy
- Publisher
- Academy of Managed Care Pharmacy
- Published
- 2016-05
- Volume
- 22
- Issue
- 5
- Pages
- 493-515
- ISSN
- 2376-0540 (ISSN-L)
- 2376-1032
- PMC
- PMC10397609
- OpenAlex
- W2345232808
- Cited by
- 199
- References
- 79
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 13 · 2023: 17 · 2022: 31 · 2021: 31 · 2020: 28 · 2019: 21 · 2018: 13 · 2017: 20 · 2016: 2
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Managed Care & Specialty Pharmacy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Universidade da Beira Interior
- Universidade de Coimbra
- Topics
- Health Sciences › Health Professions › Pharmacy › Pharmacy and Medical Practices
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- pharmacist intervention, type 2 diabetes, HbA1c, blood pressure, lipid profile, LDL cholesterol, total cholesterol, body mass index, medication adherence, health-related quality of life, coronary heart disease risk, economic outcomes, community pharmacy, primary care, hospital pharmacy, integrated care teams, diabetes management, usual care comparison, risk of bias, heterogeneity of results, publication bias
- MeSH terms
- Aged, Blood Pressure, Cost-Benefit Analysis, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Male, Middle Aged, Pharmacists, Quality of Life, Randomized Controlled Trials as Topic, Disease Management, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
